Nanoform's Clinical Study Indicates Positive Interim Results |
| January 22, 2021 | January 2021 Bond Updates |
|
HELSINKI, Jan. 22, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful. Nanoform has... |
| View more at: https://www.prnewswire.com:443/news-releases/nanoforms-clinical-study-indicates-positive-interim-results-301213028.html |
| Related News |
|